RxDoctor Payments Data

Ifeolumipo Sofola, MD

Facial Plastic Surgery · The Woodlands, TXNPI 1578621256

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $42,085 of the $48,597 with a category attached, or 86.6%. Optinose US, Inc. accounts for 95.9% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2019 at $19,300 and has fallen 99.3% since, to $144 in 2024. Among facial plastic surgery clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$48,597in general payments, 2019–2025

Across 153 payments — averaging $317.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Optinose US, Inc.$47K
  • Acclarent, Inc$836
  • Merz North America, Inc.$659
  • Integra Lifesciences Corporation$144
  • Aerin Medical Inc.$126
  • Kaleo, Inc.$86
  • plus $166 from 7 others

What the payments were for

  • Consulting fees$2,0004%
  • Speaking & faculty fees$42,08587%
  • Travel & lodging$7081%
  • Food & beverage$3,8058%

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$48,597 in reported general payments places this provider in the 95th percentile of 42 facial plastic surgery providers in Texas.

See all facial plastic surgery providers in Texas

Medicare billing

Part B allowed, 2024
$19,031
Medicare patients
91
Services billed
157

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Mometasone Furoate58$2,293
Ipratropium Bromide12$220
Clindamycin Hcl11$142
Fluticasone Propionate12$73

Paid to pharmacies, not to this prescriber.

Other facial plastic surgery in The Woodlands

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →